German economy ministry says it supports BioNTech/CureVac transaction
12/06/2025 12:54
BERLIN, June 12 (Reuters) - The German government, which holds about 13% in German biotech firm CureVac 5CV.DE, is in principle in favour of the planned takeover by domestic peer BioNTech 22UAy.DE, the economy ministry said on Thursday. The usual review procedures would now be initiated, the ministry added. (Reporting by Christian Kraemer, writing by Ludwig Burger, editing by Thomas Seythal) ((ludwig.burger@thomsonreuters.com;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028